96118-5
SARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay
Active
94761-4 SARS-CoV-2 (COVID-19) IgG Ab [Presence] in DBS by Immunoassay
Term Description
Detection of SARS-CoV-2 IgG antibodies in a dried blood spot by an immunoassay method, such as enzyme-linked immunosorbent assay (ELISA) or microsphere immunofluorescence-based assay (MIA).
Source: Regenstrief LOINC
Part Descriptions
LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.
The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus.
Source: LOINC
Reference Information
| Type | Source | Reference |
|---|---|---|
| Webcontent | Lab Tests Online®Copyright Copyright © 2021 Lab Tests Online. All rights reserved. | Coronavirus (COVID-19) Testing |
Fully-Specified Name
- Component
- SARS coronavirus 2 Ab.IgG
- Property
- PrThr
- Time
- Pt
- System
- Bld.dot
- Scale
- Ord
- Method
- IA
Additional Names
- Short Name
- SARS-CoV-2 IgG DBS Ql IA
- Display Name
- SARS-CoV-2 (COVID-19) IgG IA Ql (DBS)
- Consumer Name Alpha Get Info
- SARS-CoV-2 (COVID-19) IgG antibody, Dried blood spot
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.68
- Last Updated
- Version 2.69
- Order vs. Observation
- Both
Example Answer List LL2888-7
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Nonreactive Copyright http://snomed.info/sct ID:131194007 Non-reactive (qualifier value) | LA15256-3 | ||
| Reactive Copyright http://snomed.info/sct ID:11214006 Reactive (qualifier value) | LA15255-5 | ||
| Invalid Copyright http://snomed.info/sct ID:455371000124106 Invalid result (qualifier value) | LA15841-2 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 96118-5 | SARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG51018-6 | SARSCoV2 antibody detection |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | SARS-Coronavirus 2 Ak.IgG: |
| es-ES | Spanish (Spain) | Panel del SARS-CoV-2 (COVID-19) IgG: |
| es-MX | Spanish (Mexico) | SARS coronavirus 2 Ab.IgG: |
| fr-FR | French (France) | Coronavirus SARS-CoV-2 Ac IgG: |
| fr-CA | French (Canada) | coronavirus 2 du SRAS, IgG: |
| it-IT | Italian (Italy) | SARS coronavirus 2 Ab.IgG: Synonyms: anticorpi IgG anticorpo Coronavirus della SARS Immunoassay Microbiologia Presenza o Soglia Punto nel tempo (episodio) Sangue SARS-CoV-2 (COVID-19) Spot sangue secco |
| nl-NL | Dutch (Netherlands) | SARS-CoV-2 As.IgG: Synonyms: antistof; |
| pl-PL | Polish (Poland) | SARS-CoV-2 Ab.IgG: Synonyms: IgG Koronawirus Przeciwciała do wirusa SARS-CoV-2 (COVID-19) Przeciwciała IgG do SARS-CoV-2 (COVID-19) |
| zh-CN | Chinese (China) | SARS 冠状病毒 2 抗体.IgG: Synonyms: 2019 新型冠状病毒; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
95416-4 SARS-CoV-2 (COVID-19) IgM Ab [Presence] in DBS by Immunoassay
Term Description
Qualitative detection of IgM antibody to SARS coronavirus 2 (SARS-CoV-2) in dried blood spot specimens by immunoassay.
Source: Regenstrief LOINC
Part Descriptions
LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.
The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus.
Source: LOINC
Reference Information
| Type | Source | Reference |
|---|---|---|
| Webcontent | Lab Tests Online®Copyright Copyright © 2021 Lab Tests Online. All rights reserved. | Coronavirus (COVID-19) Testing |
Fully-Specified Name
- Component
- SARS coronavirus 2 Ab.IgM
- Property
- PrThr
- Time
- Pt
- System
- Bld.dot
- Scale
- Ord
- Method
- IA
Additional Names
- Short Name
- SARS-CoV-2 IgM DBS Ql IA
- Display Name
- SARS-CoV-2 (COVID-19) IgM IA Ql (DBS)
- Consumer Name Alpha Get Info
- SARS-CoV-2 (COVID-19) IgM antibody, Dried blood spot
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.68
- Last Updated
- Version 2.69
- Order vs. Observation
- Both
Example Answer List LL744-4
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Detected | LA11882-0 | ||
| Not detected | LA11883-8 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 96118-5 | SARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG51018-6 | SARSCoV2 antibody detection |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | SARS-Coronavirus 2 Ak.IgM: |
| es-ES | Spanish (Spain) | Panel del SARS-CoV-2 (COVID-19) IgM: |
| es-MX | Spanish (Mexico) | SARS coronavirus 2 Ab.IgM: |
| fr-CA | French (Canada) | coronavirus 2 du SRAS, IgM: |
| fr-FR | French (France) | Coronavirus SARS-CoV-2 Ac IgM: |
| it-IT | Italian (Italy) | SARS coronavirus 2 Ab.IgM: Synonyms: Anticorpi IgM anticorpo Coronavirus della SARS Immunoassay Microbiologia Presenza o Soglia Punto nel tempo (episodio) Sangue SARS-CoV-2 (COVID-19) Spot sangue secco |
| nl-NL | Dutch (Netherlands) | SARS-CoV-2 As.IgM: Synonyms: antistof; |
| pl-PL | Polish (Poland) | SARS-CoV-2 Ab.IgM: Synonyms: IgM Koronawirus Przeciwciała do wirusa SARS-CoV-2 (COVID-19) Przeciwciała IgM do SARS-CoV-2 (COVID-19) |
| zh-CN | Chinese (China) | SARS 冠状病毒 2 抗体.IgM: Synonyms: 2019 新型冠状病毒; |
95825-6 SARS-CoV-2 (COVID-19) Ab [Presence] in DBS by Immunoassay
Term Description
Qualitative detection of SARS-CoV-2 antibodies in a dried blood spot by an immunoassay method, such as enzyme-linked immunosorbent assay (ELISA), microsphere immunofluorescence-based assay (MIA), or electrochemiluminescence immunoassay (ECLIA).
Source: Regenstrief LOINC
Part Descriptions
LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.
The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus.
Source: LOINC
Reference Information
| Type | Source | Reference |
|---|---|---|
| Webcontent | Lab Tests Online®Copyright Copyright © 2021 Lab Tests Online. All rights reserved. | Coronavirus (COVID-19) Testing |
Fully-Specified Name
- Component
- SARS coronavirus 2 Ab
- Property
- PrThr
- Time
- Pt
- System
- Bld.dot
- Scale
- Ord
- Method
- IA
Additional Names
- Short Name
- SARS-CoV-2 Ab DBS Ql IA
- Display Name
- SARS-CoV-2 (COVID-19) Ab IA Ql (DBS)
- Consumer Name Alpha Get Info
- SARS-CoV-2 (COVID-19) antibody, Dried blood spot
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.69
- Last Updated
- Version 2.69
- Order vs. Observation
- Both
Example Answer List LL4994-1
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Nonreactive Copyright http://snomed.info/sct ID:131194007 Non-reactive (qualifier value) | LA15256-3 | ||
| Reactive Copyright http://snomed.info/sct ID:11214006 Reactive (qualifier value) | LA15255-5 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 96118-5 | SARS-CoV-2 (COVID-19) Ab panel - DBS by Immunoassay |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG51018-6 | SARSCoV2 antibody detection |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-DE | German (Germany) | SARS-Coronavirus 2 Ak: |
| es-MX | Spanish (Mexico) | Coronavirus 2 Ab del SARS: |
| es-ES | Spanish (Spain) | Panel del SARS-CoV-2 (COVID-19) Anticuerpos: |
| fr-FR | French (France) | Coronavirus SARS-CoV-2 Ac: |
| fr-CA | French (Canada) | coronavirus 2 du SRAS, Ac: |
| it-IT | Italian (Italy) | SARS coronavirus 2 Ab: Synonyms: anticorpo Coronavirus della SARS Immunoassay Microbiologia Presenza o Soglia Punto nel tempo (episodio) Sangue SARS-CoV-2 (COVID-19) Spot sangue secco |
| nl-NL | Dutch (Netherlands) | SARS-CoV-2 As: Synonyms: antistof; |
| pl-PL | Polish (Poland) | SARS-CoV-2 Ab: Synonyms: Koronawirus Przeciwciała do wirusa SARS-CoV-2 (COVID-19) |
| zh-CN | Chinese (China) | SARS 冠状病毒 2 抗体: Synonyms: 2019 新型冠状病毒; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.